Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors

被引:44
|
作者
Li, R. C. [1 ,2 ]
Krishnamoorthy, P. [1 ]
DerOhannessian, S. [1 ]
Doveikis, J. [1 ]
Wilcox, M. [1 ]
Thomas, P. [3 ]
Rader, D. J. [1 ,2 ]
Reilly, M. P. [1 ,2 ]
Van Voorhees, A. [4 ]
Gelfand, J. M. [2 ,4 ]
Mehta, N. N. [5 ]
机构
[1] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[5] NHLBI, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; INFLAMMATION; ADIPOKINES; EXPRESSION; IMMUNITY; OBESITY;
D O I
10.1111/ced.12250
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundPsoriasis is an inflammatory skin disease that may be associated with an adverse cardiometabolic profile including modulated plasma adiponectin and leptin levels. Whether these levels are independent of cardiometabolic risk factors, which are also prevalent in psoriasis, is not known. MethodsA consecutive sample of 122 participants with varying degrees of psoriasis severity, and a random sample of 134 participants without psoriasis, were recruited for this case-control study. Cardiometabolic risk factors including traditional cardiovascular risk factors, waist circumference, insulin resistance, and total plasma adiponectin and leptin were measured. Total plasma adiponectin and leptin levels were compared in unadjusted and adjusted analyses by psoriasis status. ResultsParticipants with psoriasis had mostly mild disease and were mainly on topical therapies, but still had a more adverse cardiometabolic profile compared with those without psoriasis. Furthermore, plasma adiponectin levels were significantly lower in participants with psoriasis than those without {7.13g/mL [interquartile range (IQR) 4.9-11.3) vs. 14.5g/mL (IQR 8.4-24.1); P<0.001]}. Plasma leptin (ng/mL) levels were higher in the psoriasis group but this did not reach statistical significance [11.3 (IQR 6.4-21.8) vs. 9.8 (IQR 4.9-20.5); P=0.07]. In multivariable modelling, plasma adiponectin levels were still negatively associated with psoriasis status after adjusting for waist size (% difference=-41.2%, P<0.001), insulin resistance (% difference=-39.5%, P<0.001), and both waist size and insulin resistance (% difference=-38.5%, P<0.001). ConclusionsPlasma levels of adiponectin were lower in psoriasis, and this relationship persisted after adjusting for cardiometabolic risk factors known to decrease adiponectin levels. These findings suggest that inflammation present in psoriasis may be associated with adipose tissue dysfunction; however, direct studies of adipose tissue are needed to confirm this.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [1] Serum Adiponectin Levels and Their Association With Cardiometabolic Risk Factors in Patients With Psoriasis
    Chan, Wai Sze Agnes
    Liew, Choon Fong
    Theng, Colin Thiam Seng
    Oon, Hazel H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [2] Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer
    Otake, Sayaka
    Takeda, Hiroaki
    Fujishima, Shoichiro
    Fukui, Tadahisa
    Orii, Tomohiko
    Sato, Takeshi
    Sasaki, Yu
    Nishise, Shoichi
    Kawata, Sumio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1252 - 1257
  • [3] Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer
    Sayaka Otake
    Hiroaki Takeda
    Shoichiro Fujishima
    Tadahisa Fukui
    Tomohiko Orii
    Takeshi Sato
    Yu Sasaki
    Shoichi Nishise
    Sumio Kawata
    World Journal of Gastroenterology, 2010, 16 (10) : 1252 - 1257
  • [4] Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age
    Ambroziak, Michal
    Kolanowska, Monika
    Bartoszewicz, Zbigniew
    Budaj, Andrzej
    GENE, 2018, 642 : 498 - 504
  • [5] ADIPONECTIN (ADIPOQ) GENE POLYMORPHISMS AND ADIPONECTIN LEVELS IN OBESE WITH AND WITHOUT CARDIOMETABOLIC RISK FACTORS
    Henneman, P.
    Maaijen, R.
    Fogteloo, A.
    van Dijk, K. Willems
    Frants, R.
    Smelt, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [6] Poor Sleep Quality is Independently Associated with Cardiometabolic Risk Factors
    Smith, Kevin L.
    Boeve, Angelica R.
    Somers, Virend K.
    Bukartyk, Jan
    St Louis, Erik K.
    Covassin, Naima
    FASEB JOURNAL, 2018, 32 (01):
  • [7] Adiponectin levels, cardiometabolic risk factors and markers of subclinical atherosclerosis in children
    Arnaiz, Pilar
    Acevedo, Monica
    Barja, Salesa
    Aglony, Marlene
    Guzman, Beatriz
    Cassis, Berta
    Carvajal, Jacqueline
    Moreno, Manuel
    Navarrete, Carlos
    Berrios, Ximena
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (02) : 138 - 144
  • [8] Plasma glutathione levels are independently associated with γ-glutamyltransferase activity in subjects with cardiovascular risk factors
    Sedda, Valentina
    De Chiara, Benedetta
    Parolini, Marina
    Caruso, Raffaele
    Campolo, Jonica
    Cighetti, Giuliana
    De Maria, Renata
    Sachero, Aldo
    Donato, Luigi
    Parodi, Oberdan
    FREE RADICAL RESEARCH, 2008, 42 (02) : 135 - 141
  • [9] Relation between plasma levels of adiponectin, cardiometabolic risk factors and adiponectin gene expression in visceral adipose tissue, in a group of severely obese patients
    Sirbu, A.
    Barbu, C.
    Reghina, A.
    Munteanu, C.
    Kervorkian, S.
    Copaescu, C.
    Nicolae, H.
    Florea, S.
    Fica, S.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S64 - S64
  • [10] An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance
    González-Sánchez, JL
    Zabena, CA
    Martínez-Larrad, MT
    Fernández-Pérez, C
    Pérez-Barba, M
    Laakso, M
    Serrano-Ríos, M
    OBESITY RESEARCH, 2005, 13 (05): : 807 - 812